Medicixi raises 400 mln euros for third fund
Medicixi, a European life sciences investment firm, has closed its third fund at 400 million euros. The investors in Medicixi III include Novartis and Johnson & Johnson Innovation – JJDC, Inc. The fund will invest in early and late-stage biopharma companies.
19 July 2019•3 mins read
